Chargement en cours...
Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
The use of monoclonal neutralizing antibodies (mNAbs) is being actively pursued as a viable intervention for the treatment of Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) infection and associated coronavirus disease 2019 (COVID-19). While highly potent mNAbs have great therapeutic potential,...
Enregistré dans:
| Publié dans: | J Virol Methods |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier B.V.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7837211/ https://ncbi.nlm.nih.gov/pubmed/33513380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jviromet.2021.114084 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|